CARDIOVASCULAR MEDICINE

Prosthetic valve endocarditis: early and late outcome following medical or surgical treatment

E F Akowuah¹, W Davies¹, S Oliver¹, J Stephens¹, I Riaz¹, P Zadik², G Cooper¹

¹ Department of Cardiothoracic Surgery, Northern General Hospital, Herries Road, Sheffield, UK
² Department of Microbiology, Northern General Hospital

Correspondence to:
Correspondence to:
Mr Graham Cooper, Department of Cardiothoracic Surgery, Northern General Hospital, Herries Road, Sheffield S5 5AU, UK;
graham.cooper{at}sth.nhs.uk

Objective: To compare the early and late outcome of medical and surgical treatment in patients with prosthetic valve endocarditis within a single unit.

Design: All patients with proven prosthetic valve endocarditis treated in one institution between 1989 and 1999 were studied.

Results: There were 66 patients (24 female, 42 male), mean (SD) age 57 (14) years. Of these, 28 were treated with antibiotics alone and 38 with a combination of antibiotics and surgery. The in-hospital mortality for the antibiotic group was 46% and for the surgical group, 24%. However, seven patients in the antibiotic group were considered too sick for curative treatment. The mortality in the remaining 21 medically treated patients (6/21; 29%) was not significantly different from that in the surgically treated patients (p = 0.15). Six patients in the medically treated group and one in the surgically treated group required late reoperation. Endocarditis recurred in three patients in the medically treated group, two of whom were treated surgically, and in one patient in the surgically treated group. Kaplan–Meier survival at 10 years was 28% in the medically treated group v 58% in the surgically treated group (p = 0.04). Freedom from endocarditis at five years was 60% in the surgically treated group and 65% in the medically treated group.

Conclusions: Prosthetic valve endocarditis is a serious condition with high early and late mortality, irrespective of the treatment employed. These data show that selected patients with prosthetic valve endocarditis can be successfully treated with antibiotics alone. If required, surgery in this difficult group of patients can provide satisfactory freedom from recurrent infection.

Keywords: prosthetic valve endocarditis; antibiotic treatment; surgical treatment

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Endorsed by the European Society of Clinical Micro, , Authors/Task Force Members, , Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., Lekakis, J., Lengyel, M., Muller, L., Naber, C. K., Nihoyannopoulos, P., Moritz, A., Zamorano, J. L., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Auricchio, A., Bax, J., Ceconi, C., Dean, V., Filippatos, G., Funck-Brentano, C., Hobbs, R., Kearney, P., McDonagh, T., McGregor, K., Popescu, B. A., Reiner, Z., Sechtem, U., Sirnes, P. A., Tendera, M., Vardas, P., Widimsky, P., Document Reviewers, , Vahanian, A., Aguilar, R., Bongiorni, M. G., Borger, M., Butchart, E., Danchin, N., Delahaye, F., Erbel, R., Franzen, D., Gould, K., Hall, R., Hassager, C., Kjeldsen, K., McManus, R., Miro, J. M., Mokracek, A., Rosenhek, R., San Roman Calvar, J. A., Seferovic, P., Selton-Suty, C., Uva, M. S., Trinchero, R., van Camp, G. (2009). Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30: 2369-2413 [Full Text]  
• Lopes, S., Calvinho, P., de Oliveira, F., Antunes, M. (2007). Allograft aortic root replacement in complex prosthetic endocarditis. Eur. J. Cardiothorac. Surg. 32: 126-130 [Abstract] [Full Text]  
• Wang, A., Athan, E., Pappas, P. A., Fowler, V. G. Jr, Olaison, L., Pare, C., Almirante, B., Munoz, P., Rizzi, M., Naber, C., Logar, M., Tattevin, P., Iarussi, D. L., Selton-Suty, C., Jones, S. B., Casabe, J., Morris, A., Corey, G. R., Cabell, C. H., for the International Collaboration on Endocarditi, (2007). Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis. JAMA 297: 1354-1361 [Abstract] [Full Text]  
• Lopez, J., Revilla, A., Vilacosta, I., Villacorta, E., Gonzalez-Juanatey, C., Gomez, I., Rollan, M. J., San Roman, J. A. (2007). Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J 28: 760-765 [Abstract] [Full Text]  
• Habib, G, Tribouilloy, C, Thuny, F, Giorgi, R, Brahim, A, Amazouz, M, Remadi, J-P, Nadji, G, Casalta, J-P, Coviaux, F, Avierinos, J-F, Lescure, X, Riberi, A, Weiller, P-J, Metras, D, Raoult, D (2005). Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart 91: 954-959 [Abstract] [Full Text]  
• Vassalos, A., Dancer, S.J., MacArthur, K.J.D. (2004). Polymerase chain reaction diagnosis in culture-negative prosthetic valve methicillin-resistant Staphylococcus aureus endocarditis in a patient with chronic liver disease. ICVTS 3: 240-242 [Abstract] [Full Text]  
• Ramos, J. M., Cuenca-Estrella, M., Gutierrez, F., Elia, M., Rodriguez-Tudela, J. L. (2004). Clinical Case of Endocarditis due to Trichosporon inkin and Antifungal Susceptibility Profile of the Organism. J. Clin. Microbiol. 42: 2341-2344 [Abstract] [Full Text]  
• Darouiche, R. O. (2004). Treatment of Infections Associated with Surgical Implants. NEJM 350: 1422-1429 [Full Text]  
• Durack, D. T. (2003). Evaluating and Optimizing Outcomes of Surgery for Endocarditis. JAMA 290: 3250-3251 [Full Text]  
• Tornos, P (2003). Management of prosthetic valve endocarditis: a clinical challenge. Heart 89: 245-246 [Full Text]